Sequent Scientific has informed that the Board of Directors of the Company on August 13, 2015 has approved the allotment of 757,734 equity shares at a price of Rs 669.10 per equity share (including a premium of Rs 659.10 per equity share) to Devicam Capital LLP, a promoter group entity by way of preferential issue in compliance with Chapter VII of the Securities & Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009. Consequent to the allotment, the paid up equity share capital of the Company has increased from Rs. 412,618,260 consisting of 41,261,826 equity shares of Rs 10 each to Rs 420,195,600 consisting of 42,019,560 equity shares of Rs 10 each.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: